There are 2789 resources available
1555TiP - A phase II single-arm study of pembrolizumab plus lenvatinib in previously treated classic Kaposi sarcoma (CKS): The PULSAR trial
Presenter: Alice Indini
Session: ePoster Display
1568P - Clinical and laboratory outcomes of solid cancer patients reinfected with SARS-CoV-2
Presenter: Ozan Yazıcı
Session: ePoster Display
1569P - A multicenter analysis of the outcome of cancer patients with neutropenia and COVID-19 infection optionally treated with granulocyte colony-stimulating factor (G-CSF): A comparative analysis
Presenter: Maria Sereno Moyano
Session: ePoster Display
1570P - Outcome and prognostic factors of COVID-19 infection in cancer patients: Final results of SAKK 80/20
Presenter: Markus Joerger
Session: ePoster Display
1518P - Treating cancer with unknown primary (CUP) in Germany – an economic perspective
Presenter: Bernhard Mörtl
Session: ePoster Display
1519TiP - Japanese Society of Medical Oncology/Health Authority of the Japanese Government Cooperative Virtual Educational Program for Improving the Clinical Annotation for Cancer Genomic Medicine
Presenter: Toraji Amano
Session: ePoster Display
1528P - Prospective IAWS registry to optimize either neo- or adjuvant treatment strategies for adult patients with large sized, high grade soft tissue sarcoma (NRSTS)
Presenter: Jörg Hartmann
Session: ePoster Display
1529P - Treatment results in elderly patients (pts) diagnosed with locally advanced soft tissue sarcoma (STS)
Presenter: Hanna Kosela Paterczyk
Session: ePoster Display
1530P - Outcome of primary soft tissue or bone myoepithelial tumors (METs)
Presenter: Sarah CAVAILLON
Session: ePoster Display